Moxifloxacin Hydrochloride
Spezifikationen
186826-86-8CAS-Nummer
641-756-7EG-Nummer
7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochlorideIUPAC-Name
C21H25ClFN3O4Chemische Formel
437.9 g/molMolekulargewicht
Moxifloxacin hydrochloride; 186826-86-8; Moxifloxacin HCl; Vigamox; BAY 12-8039; Moxivig; Moxeza; DTXSID4045921; Bay-12-8039; Moxifloxacin (as hydrochloride); AL-15469A; NSC-758875; CHEBI:7008; (4aS-cis)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolol(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid, monohydrochloride; AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER; C53598599T; DTXCID2025921; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid, monohydrochloride; Avelox Abc Pack; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, monohydrochloride; Moxifloxacin Ophthalmic; RefChem:6657; Moxifloxacin Ophthalmic Solution; BAY 128039; BAY 12 8039; MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER; MFCD00949117; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (1:1); Moxifloxacin (Hydrochloride); C21H25ClFN3O4; 1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride; 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride; 7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride; Vigamox (TN); Avelox (TN); 1346603-25-5; CAS-186826-86-8; Moxifloxacin hydrochloride [USAN]; Octegra; Vegamox; BAY12-8039 HCl; UNII-C53598599T; NCGC00095130-01; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride; d-Moxifloxacin Hydrochloride; (4R,7R)-Moxifloxacin Hydrochloride;; 1-Cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl]-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride; 1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride; 1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride; BAY12-8039; Moxifloxacin hydrochloride [USAN:USP]; CPD000469185; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride; Moxifloxacin hydrochloride RS; SCHEMBL37285; 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid hydrochloride; MLS001401368; Moxifloxacin hydrochloride CRS; orb1225846; orb1310715; orb3139897; CHEMBL1200735; MOXIFLOXACIN HCL [VANDF]; SCHEMBL29379369; MSK5732; 186826-86-8 (HCl); 354812-41-2 (free base); GLXC-04757; Tox21_111439; EBC-11295; HY-66011R; MSK5732-100D; MSK5732-100M; Moxifloxacin hydrochloride (JAN/USP); AKOS015920132; AKOS016015225; MSK5732-1000M; Tox21_111439_1; AC-1275; AM10805; CCG-100924; KS-1181; MOXIFLOXACIN HYDROCHLORIDE [MI]; NC00174; NSC 758875; Moxifloxacin (Hydrochloride) (Standard); MOXIFLOXACIN HYDROCHLORIDE [JAN]; NCGC00271749-02; 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-, monohydrochloride; HY-66011; MOXIFLOXACIN HYDROCHLORIDE [MART.]; SMR000469185; SY108424; MOXIFLOXACIN HYDROCHLORIDE [USP-RS]; MOXIFLOXACIN HYDROCHLORIDE [WHO-DD]; Moxifloxacin hydrochloride, >=98% (HPLC); M2479; M5794; S1465; SW197554-3; C08054; D00874; MOXIFLOXACIN HYDROCHLORIDE [ORANGE BOOK]; EN300-2009156; MOXIFLOXACIN HYDROCHLORIDE [EP MONOGRAPH]; MOXIFLOXACIN HYDROCHLORIDE [USP MONOGRAPH]; Moxifloxacin hydrochloride Solution in DMSO, 100ug/mL; Q27107395; Z2235801869; 186826-86-8 151096-09-2(base); Moxifloxacin hydrochloride Solution in Methanol, 1000ug/mL; Moxifloxacin hydrochloride Solution in Methanol, 100ug/mL; Moxifloxacin hydrochloride, VETRANAL(TM), analytical standard; Moxifloxacin hydrochloride, European Pharmacopoeia (EP) Reference Standard; Moxifloxacin for peak identification, European Pharmacopoeia (EP) Reference Standard; Moxifloxacin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Moxifloxacin hydrochloride, United States Pharmacopeia (USP) Reference Standard; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride; 1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid HCl; 1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylicacidhydrochloride; 1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-((4aS,7aS)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride; 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid--hydrogen chloride (1/1); 3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-, hydrochloride (1:1); 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid;hydrochloride; 7-[[(4As,8aS)-2,3,4,4a,5,6,8,8a-octahydro-1H-1,7-naphthyridin-7-yl]methyl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride; BAY-12-8039; Actira; Avalox; Proflox; 1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochlorideSynonyme
Produkte, die Moxifloxacin Hydrochloride enthalten
목시플점안액(목시플록사신염산염)(수출용) 리목신점안액(목시플록사신염산염)휴목시점안액(목시플록사신염산염)국제목시플록사신염산염점안액(수출용)목시프로점안액(목시플록사신염산염)플로나신점안액(목시플록사신염산염)목시타신점안액(목시플록사신염산염)목시휴점안액(목시플록사신염산염)라이트목시점안액(목시플록사신염산염)목시탄점안액(목시플록사신염산염)목시프란점안액(목시플록사신염산염)코러스목시플록사신정400밀리그램(목시플록사신염산염)(수출용)
Seite 1 von 10
Unternehmen, die Moxifloxacin Hydrochloride verkaufen
한미
한미약품(주)Republic of Korea(주
(주)휴온스Republic of Korea한림
한림제약(주)Republic of KoreaSeite 1 von 9